Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (273)
- COVID-19 (163)
- Safety monitoring and information (97)
- Legislation (93)
- Compliance and enforcement (66)
- Vaping hub (53)
- Manufacturing (52)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Import and export (26)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1258 result(s) found, displaying 1001 to 1025
-
BlogIn a bushfire or other natural disaster you might need emergency access to an important medicine. Here are some tips on how to plan ahead.
-
BlogThis Australia Day, we celebrate some Australian innovators in therapeutic goods.
-
Media releasesMeasles vaccine testing shows the vaccine meets required standards
-
News articlesThe Health Products Regulation Group has published a new regulatory science strategy
-
-
Media releasesPharmacies and others can advertise availability of OTC salbutamol products during the bushfire season
-
Regulatory decision noticesOn 20 November 2019 the TGA issued a direction notice to Cat Media concerning its advertising of Fatblaster Clinical
-
BlogAbuse of human growth hormone can cause permanent health issues.
-
Media releasesMundipharma Pty Ltd has paid penalties of $302,400 in response to 24 infringement notices issued by the TGA
-
-
Regulatory decision noticesA new S41BD(3) instrument has been signed to declare that some nappy rash products are not to be medical devices for the purposes of the Act
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
-
Regulatory decision noticesNew requirements for listed medicines containing Andrographis paniculata
-
News articlesSome label warnings no longer required for medicines containing very low concentrations of menthol or methyl salicylate
-
Media releasesWe will closely consider the judgment including any further improvements that could enhance the regulatory system in Australia.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Media releasesAcalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada
-
Media releasesThe TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance
-
Media releasesConsumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
-
News articlesGeneral information for consumers on prescription opioids
-
BlogFrom animals intestines to intrauterine devices, contraception has a fascinating history.
-
-
Media releasesThe Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated